Sign up to save your podcasts
Or
Share PRAC Valproate Review, JCA Scale-Up, Emergency Trial Guidance
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
PRAC Valproate Review, JCA Scale-Up, Emergency Trial Guidance
Episode 31 — 15 June 2026
EMA's PRAC concludes valproate neurodevelopmental risk remains uncertain while EU JCA programme scales to 50 assessments in 2026. Emergency clinical trial guidance opens for consultation as oral GLP-1 approvals expand market access complexity.
Hosted by Marcus and Sara.
Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.
Full transcript and sources at outcomes-analytica.no/podcast
View all episodes
By Carl HaakonEpisode 31 — 15 June 2026
EMA's PRAC concludes valproate neurodevelopmental risk remains uncertain while EU JCA programme scales to 50 assessments in 2026. Emergency clinical trial guidance opens for consultation as oral GLP-1 approvals expand market access complexity.
Hosted by Marcus and Sara.
Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape.
Full transcript and sources at outcomes-analytica.no/podcast